DNA-based career guidance startup GenLeap raised $3.3 million in Pre-Series A where existing investors- Embassy REIT’s Mike Holland, Tata Realty’s Sanjay Dutt, Olam Food’s Karthikeyan Balasubramanian, Deepak Kaul and Manish Dhawan, KPMG’s Neeraj Bansal with new investors including Policybazaar’s CFO Mandeep Mehta, Embassy REIT’s Vikaash Khdloya, Sunil Bajaj and Yoguen Oukabay were also participated.
Among other things, GenLeap provides DNA-based services for career advancement and development, health and wellness, relationship compatibility, and disease susceptibility. GenLeap’s US entity will be listed on the ‘Regulation A Plus IPO’ market in the United States, with plans to launch a $50 million IPO there shortly. The startup will use the funds from this round of funding and the IPO to expand its marketing and distribution footprint globally. It also intends to expand into the United States, the Middle East, and Europe. Furthermore, it intends to use the IPO proceeds to build research and development labs around the world and to expand its research in emerging areas such as behavioural genetics.